Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryotherapy vs. TCA 90% for Common Warts
NCT05712811Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- Jun 2022
- Primary completion
- Nov 2022
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nitrogen and trichloroacetic acid in common warts, sponsored by Combined Military Hospital Abbottabad. Primary endpoint: Complete Clearance of Common Warts at 12 weeks. Started Jun 2022; status: completed.
02
Drugs
nitrogentrichloroacetic acid
03
Conditions
common warts
Beyond the preview
Go deeper on NCT05712811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05712811.